• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦 1978-2007 年外阴原位和侵袭性鳞状细胞癌:一项基于人群的全国性研究。

In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study.

机构信息

Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.

出版信息

Gynecol Oncol. 2011 Jul;122(1):45-9. doi: 10.1016/j.ygyno.2011.03.016. Epub 2011 Apr 7.

DOI:10.1016/j.ygyno.2011.03.016
PMID:21474166
Abstract

OBJECTIVE

To determine the incidence of vulvar carcinoma in situ (CIS) and cancer of squamous cell (SC) origin in Denmark in the period 1978-2007.

METHODS

Using the nationwide Danish Cancer Registry, we identified 980 women diagnosed with vulvar CIS 1978-2003 (67.8% were SC) and 2455 women diagnosed with vulvar cancer 1978-2007 (76.0% were SC). Analysis was restricted to vulvar CIS and cancer of SC origin. We assessed age-specific incidence rates, age-standardized incidence rates, and distribution of stage at diagnosis. Poisson regression analysis was used to estimate the average annual percentage change.

RESULTS

During the study period the age-standardized incidence rate of vulvar SC CIS increased by 1.97% per year (95% CI: 0.99% to 2.96%) with a tendency toward a steeper increase among women younger than 50 years. The age-standardized incidence rate of vulvar SC cancer showed a stable or slightly increasing pattern. However, among women below 60 years of age a significantly increasing trend was observed (1.60% per year; 95% CI: 0.50% to 2.71%). The distribution in the extent of vulvar SC cancer at diagnosis showed a tendency toward a higher proportion being diagnosed with localized disease in the more recent calendar years.

CONCLUSIONS

The incidence rates of vulvar SC CIS and vulvar SC cancer among women below the age of 60 years have increased since 1978. Human papillomavirus (HPV) could explain the increase and thus, the recent introduction of HPV vaccination may in the future result in a notable reduction of vulvar malignancies.

摘要

目的

确定 1978 年至 2007 年期间丹麦外阴原位癌(CIS)和鳞状细胞癌(SC)起源癌症的发病率。

方法

我们使用全国性的丹麦癌症登记处,确定了 980 名 1978 年至 2003 年诊断为外阴 CIS 的女性(67.8%为 SC)和 2455 名 1978 年至 2007 年诊断为外阴癌的女性(76.0%为 SC)。分析仅限于外阴 CIS 和 SC 起源的癌症。我们评估了特定年龄的发病率、年龄标准化发病率和诊断时的分期分布。使用泊松回归分析来估计平均年百分比变化。

结果

在研究期间,外阴 SC CIS 的年龄标准化发病率每年增加 1.97%(95%CI:0.99%至 2.96%),50 岁以下女性的增长趋势更为陡峭。外阴 SC 癌的年龄标准化发病率呈稳定或略有增加的趋势。然而,60 岁以下女性的发病率呈显著上升趋势(每年 1.60%;95%CI:0.50%至 2.71%)。诊断时外阴 SC 癌的范围分布呈倾向于近期更常诊断为局限性疾病的趋势。

结论

自 1978 年以来,60 岁以下女性外阴 SC CIS 和外阴 SC 癌的发病率有所增加。人乳头瘤病毒(HPV)可能解释了这种增加,因此,HPV 疫苗的最近引入可能会在未来显著降低外阴恶性肿瘤的发病率。

相似文献

1
In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study.丹麦 1978-2007 年外阴原位和侵袭性鳞状细胞癌:一项基于人群的全国性研究。
Gynecol Oncol. 2011 Jul;122(1):45-9. doi: 10.1016/j.ygyno.2011.03.016. Epub 2011 Apr 7.
2
Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.16型人乳头瘤病毒与外阴原位癌和浸润性癌风险:一项血清流行病学病例对照研究的结果
Obstet Gynecol. 1997 Nov;90(5):748-54. doi: 10.1016/S0029-7844(97)00467-5.
3
Increased incidence of penile cancer and high-grade penile intraepithelial neoplasia in Denmark 1978-2008: a nationwide population-based study.丹麦 1978-2008 年阴茎癌和高级别阴茎上皮内瘤变发病率增加:一项全国范围内基于人群的研究。
Cancer Causes Control. 2012 Feb;23(2):273-80. doi: 10.1007/s10552-011-9876-7. Epub 2011 Nov 19.
4
Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women.外阴肿瘤的趋势。年轻女性外阴上皮内瘤变和外阴鳞状细胞癌的发病率不断上升。
J Reprod Med. 2000 Aug;45(8):613-5.
5
Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.人乳头瘤病毒在宫颈癌幸存者后续原发性原位癌和浸润性癌发生中的潜在作用。
Cancer. 2008 Nov 15;113(10 Suppl):2919-25. doi: 10.1002/cncr.23746.
6
Trends in the incidence of invasive and in situ vulvar carcinoma.浸润性和原位外阴癌的发病率趋势。
Obstet Gynecol. 2006 May;107(5):1018-22. doi: 10.1097/01.AOG.0000210268.57527.a1.
7
The pathology of vulvar neoplasia.外阴肿瘤的病理学
Curr Opin Obstet Gynecol. 1996 Feb;8(1):63-8.
8
Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age.确诊外阴上皮内瘤变(VIN)后,外阴鳞状细胞癌的发病率随年龄增长而增加。
Eur J Cancer. 2009 Mar;45(5):851-6. doi: 10.1016/j.ejca.2008.11.037. Epub 2008 Dec 29.
9
Primary vulvar neoplasia: a review of in situ and invasive carcinoma, 1935-1972.原发性外阴肿瘤:1935年至1972年原位癌和浸润癌综述
Obstet Gynecol. 1977 Apr;49(4):404-11.
10
Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination.外阴病变的人乳头瘤病毒(HPV)特征:对外阴鳞状细胞癌前病变分类及预防性HPV疫苗疗效的潜在影响
Am J Surg Pathol. 2007 Dec;31(12):1834-43. doi: 10.1097/PAS.0b013e3180686d10.

引用本文的文献

1
Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma.外阴鳞状细胞癌的临床、组织病理学及免疫组织化学分析
Rev Bras Ginecol Obstet. 2024 Dec 4;46. doi: 10.61622/rbgo/2024rbgo91. eCollection 2024.
2
Influence of stage and age on survival of patients with vulvar cancer in Germany: a retrospective study.德国外阴癌患者生存的分期和年龄影响:一项回顾性研究。
BMJ Open. 2024 Aug 28;14(8):e077960. doi: 10.1136/bmjopen-2023-077960.
3
Structure and transcription of integrated HPV DNA in vulvar carcinomas.
外阴癌中整合型人乳头瘤病毒DNA的结构与转录
NPJ Genom Med. 2024 Jun 19;9(1):35. doi: 10.1038/s41525-024-00418-8.
4
Vulvar cancer incidence and net survival in Sweden 1960 to 2019: A population-based national study.瑞典 1960 年至 2019 年外阴癌发病与净生存率:一项基于人群的全国性研究。
Acta Obstet Gynecol Scand. 2024 Mar;103(3):561-571. doi: 10.1111/aogs.14747. Epub 2023 Dec 9.
5
Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990-2015).意大利外阴鳞状细胞癌的净生存率趋势(1990 - 2015年)
J Clin Med. 2023 Mar 10;12(6):2172. doi: 10.3390/jcm12062172.
6
Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980-2018).波兰妇科和乳腺癌的发病率及死亡率趋势(1980 - 2018年)
Clin Epidemiol. 2022 Jan 24;14:95-114. doi: 10.2147/CLEP.S330081. eCollection 2022.
7
Prevalence and Treatment of Vulvar Cancer From 2014-2018: A Nationwide Population-Based Study in Korea.2014-2018 年韩国全国人群外阴癌的发病与治疗:一项基于人群的研究
J Korean Med Sci. 2022 Jan 24;37(4):e25. doi: 10.3346/jkms.2022.37.e25.
8
Prevalence and type distribution of human papillomavirus infections in Danish patients diagnosed with vulvar squamous cell tumors and precursors.丹麦诊断为外阴鳞状细胞瘤及癌前病变患者中人乳头瘤病毒感染的患病率及类型分布
Gynecol Oncol Rep. 2021 Jul 5;37:100828. doi: 10.1016/j.gore.2021.100828. eCollection 2021 Aug.
9
The Major Constituent of Green Tea, Epigallocatechin-3-Gallate (EGCG), Inhibits the Growth of HPV18-Infected Keratinocytes by Stimulating Proteasomal Turnover of the E6 and E7 Oncoproteins.绿茶的主要成分表没食子儿茶素-3-没食子酸酯(EGCG)通过刺激E6和E7癌蛋白的蛋白酶体周转来抑制人乳头瘤病毒18型(HPV18)感染的角质形成细胞的生长。
Pathogens. 2021 Apr 11;10(4):459. doi: 10.3390/pathogens10040459.
10
Four-decade trends in lymph node status of patients with vulvar squamous cell carcinoma in northern Italy.意大利北部外阴鳞癌患者淋巴结状态的 40 年趋势。
Sci Rep. 2021 Mar 11;11(1):5661. doi: 10.1038/s41598-021-85030-x.